Australia markets closed

Bioceres Crop Solutions Corp. (BIOX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.14+0.31 (+2.62%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 735.32M
Enterprise value 930.51M
Trailing P/E 34.68
Forward P/E 9.79
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.70
Price/book (mrq)2.45
Enterprise value/revenue 2.05
Enterprise value/EBITDA 14.36

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 317.13%
S&P500 52-week change 322.38%
52-week high 314.20
52-week low 39.76
50-day moving average 312.63
200-day moving average 312.24

Share statistics

Avg vol (3-month) 356.81k
Avg vol (10-day) 331.08k
Shares outstanding 560.57M
Implied shares outstanding 662.85M
Float 819.91M
% held by insiders 151.09%
% held by institutions 131.25%
Shares short (15 Apr 2024) 4280.45k
Short ratio (15 Apr 2024) 48.42
Short % of float (15 Apr 2024) 41.00%
Short % of shares outstanding (15 Apr 2024) 40.46%
Shares short (prior month 15 Mar 2024) 4291.18k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 4.83%
Operating margin (ttm)10.54%

Management effectiveness

Return on assets (ttm)3.93%
Return on equity (ttm)7.24%

Income statement

Revenue (ttm)454.53M
Revenue per share (ttm)7.24
Quarterly revenue growth (yoy)48.40%
Gross profit (ttm)N/A
EBITDA 68.36M
Net income avi to common (ttm)21.96M
Diluted EPS (ttm)0.35
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)41.44M
Total cash per share (mrq)0.66
Total debt (mrq)236.64M
Total debt/equity (mrq)70.58%
Current ratio (mrq)1.24
Book value per share (mrq)4.78

Cash flow statement

Operating cash flow (ttm)29.55M
Levered free cash flow (ttm)16.7M